Carobsyn

Carobsyn is an early-stage biotechnology company based in the Helix 51 biomedical incubator at Rosalind Franklin University in North Chicago, Illinois. The company is part of a growing cluster of life science startups in Lake County and focuses on advancing research and development of novel therapeutic or diagnostic options. As a recent addition to the Helix 51 roster, Carobsyn operates within an ecosystem that emphasizes research in cancer, immune disorders, genetic and infectious diseases, diabetes, orthopedic conditions, and neuroscience. The company likely leverages technologies licensed from leading academic and healthcare institutions in the Chicago regional bioscience hub.